CMMB

Chemomab Therapeutics

10 hedge funds and large institutions have $82.4M invested in Chemomab Therapeutics in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$74M 2,578,174 +2,578,174 New
MS
2
Maven Securities
Jersey
$3.63M 126,562 +126,562 New
CH
3
CVI Holdings
Delaware
$2.69M 93,750 +93,750 New
BFM
4
Boothbay Fund Management
New York
$1.77M 61,761 +61,761 New
Renaissance Technologies
5
Renaissance Technologies
New York
$202K 7,023 -78,452 -92%
UBS Group
6
UBS Group
Switzerland
$24K 834 +834 New
Morgan Stanley
7
Morgan Stanley
New York
$10K 334 -7,819 -96%
IF
8
Ironwood Financial
Arizona
$5K 167 +167 New
TRCT
9
Tower Research Capital (TRC)
New York
$2K 76 +76 New
MIH
10
Meitav Investment House
Israel
$239 8,311 +8,311 New
VF
11
Virtu Financial
New York
-69,653 Closed
RC
12
RegentAtlantic Capital
New Jersey
-25,000 Closed
Citadel Advisors
13
Citadel Advisors
Florida
-12,168 Closed
CFGS
14
Concourse Financial Group Securities
Alabama